The four strategies outlined include the following:
1. Establish a unique device identification system and promote its incorporation into electronic health information
2. Promote the development of national and international device registries for selected products
3. Modernize adverse event reporting and analysis
4. Develop and use new methods for evidence generation, synthesis and appraisal
The FDA will host four public meetings this month to garner public feedback.
More Articles on Orthopedic Devices:
Bioimplants Market to Reach $134B
Judge Rejects Orthofix’s Settlement Over Medicare Fraud Case
DePuy Wins Patent for Spine Cage Instruments
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.